The efficiency of single agent docetaxel in patients with platinum-refractory non-small cell lung carcinoma

Medical Oncology

Volumn 25, Issue 4, 2008, Pages 408-414

  Uygun, Kazim ^a   Aksu, Gorkem ^a   Cicin, Irfan ^b   Karagol, Hakan ^b   Kocak, Zafer ^b   Fayda, Merdan ^a   Binici, Ahmet ^a   Uzunoglu, Fernaz ^b  

^a KOCAELI UNIVERSITY   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Docetaxel; Gemcitabine; NSCLC; Radiotherapy; Second line

Indexed keywords

ALBUMIN; DOCETAXEL; LACTATE DEHYDROGENASE; PLATINUM COMPLEX;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER SURVIVAL; CARDIOTOXICITY; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; MONOTHERAPY; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; THERAPY DELAY; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLATINUM COMPOUNDS; SALVAGE THERAPY; TAXOIDS;

EID: 58549108446     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-008-9055-1     Document Type: Article

References (11)

1. Non-small Cell Lung Cancer Collaborative Group 1995 Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 clinical randomized trials BMJ 311 899 909
2. E Rapp J Pater A Willan Y Cormier N Murray WK Evans 1988 Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial J Clin Oncol 6 633 41
3. J Noble PM Ellis JA Mackay WK Ewans Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence Based Care 2006 Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline J Thorac Oncol 1 9 1042 58
4. P Bedano NH Hanna 2006 Salvage therapy in patients with advanced non-small cell lung cancer J Thorac Oncol 1 582 7
5. J Vansteenkiste 2006 Second-line therapeutic options in non-small-cell lung cancer Kung Cancer 54S S15 8
6. RA Stahel 2006 Non-small cell lung cancer: second-line and beyond Ann Oncol 17 Suppl 10 97 100
7. F Barlesi W Jacot P Astoul JL Pujol 2006 Second-line treatment for advanced non-small cell lung cancer: a systematic review Lung Cancer 51 159 72
8. FA Shepherd J Dancey R Ramlau K Mattson R Gralla M O'Rourke 2000 Prospective randomized trial of docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy J Clin Oncol 18 2095 103
9. J Dancey FA Shepherd RJ Gralla YS Kim 2004 Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial Lung Cancer 43 183 94
10. K Mattson L Bosquee G Dabouis A Le Groumellec JL Pujol S Marien 2000 Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice Lung Cancer 29 205 16
11. K Su